Top Biotech Penny Stocks to Watch — June 9, 2021

What’s up with biotech penny stocks lately?

Seems like Reddit and meme stocks are getting all the attention these days. Is there any room left for biotechs?

Of course there are — plenty of opportunities.

These are some of the sketchiest stocks in the market. They move on hype, speculation, and BS news. And there’s no shortage of any of that in this market.

So don’t just narrow down your watchlist to the most popular stocks. Build your watchlist based on the patterns and strategies that work for you.

These biotech penny stocks could offer you those opportunities.

This week’s watchlist is moving on the usual drug news hype and chart patterns. But there are also some moving on some positive news in SEC filings.

If you don’t know how to read SEC filings, get my DVD “Read SEC Filings” now. I made it with my first millionaire student, Michael Goode.*

There’s so much information in SEC filings. If you trade listed stocks, it’s a must-watch, in-depth lesson.

Now, here’s the list of top biotech penny stocks I’m watching this week and why.

Top Biotech Penny Stocks to Watch

These are the top stocks on my watchlist. ‘Watch’ is the key word here. There’s no guarantee that there’ll be a trading opportunity. Remember, these stocks move FAST.

Before we get to my list of stocks to watch, here are a few of my top resources for penny stocks…

How do I find hot stocks? I use StocksToTrade every day. For me, it’s the best tool because I helped design it specifically for trading penny stocks. (I’m also an investor.) It has awesome charts, built-in scans, social media feeds, and so much more to help you do your research.

And its Breaking News Chat add-on feature is a game-changer in this hot market. It helped me make record profits in 2020.* Get a StockToTrade 14-day trial for only $7

Or try it with the Breaking News Chat for only $17!

Now, let’s get to the top biotech penny stocks to watch this week…

Biotech Penny Stocks #1: Hoth Therapeutics, Inc. (NASDAQ: HOTH)

HOTH develops treatments for skin conditions like eczema and psoriasis.

On June 7, the company announced it entered a research agreement with Washington University to research and develop its potential treatment for Alzheimer’s.

Read the full press release here.

The stock had a big move following the news but couldn’t hold its gains. It has a history of failed spikes. I’ll watch for a potential play if it can get above $1.75.


Biotech Penny Stocks #2: Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)

SPPI develops oncology drugs.

On June 4 the company released data that was part of its poster presentation at the American Society of Clinical Oncology (ASCO) annual meeting held over the weekend.

“Data from Cohorts 1, 2 and 3 of the ongoing ZENITH20 clinical trial assessed the results from 36 patients with brain metastases at baseline with three patients (8%) achieving intracranial complete responses.”

Read the full press release here.

On Monday, June 7, the stock had a multi-day breakout. The next day it gapped up but had a morning panic. I’ll watch it for a potential bounce.


Biotech Penny Stocks #3: Vaccinex, Inc. (NASDAQ: VCNX)

VCNX develops potential treatments for cancer and autoimmune diseases.

On June 8, the company announced it “plans to activate at least 13 clinical sites for Alzheimer’s study and 18 clinical sites for head and neck cancer across the United States.”

Read the full press release here.

The stock had its first green day following the news. The next day it gapped up but faded as the overall markets dipped. I’ll watch for a potential bounce. Ideally, it can break out above $3.30.


Biotech Penny Stocks #4: Cyclerion Therapeutics, Inc. (NASDAQ: CYCN)

CYCN develops medicine for nervous systems disorders.

The stock was trading higher on June 8 after the company reported insider buying in SEC filings. It had a multi-month breakout over $3.70 and made a high of $4.40.

It has a history of big one-day spikes so I’ll watch it for continuation. But swing for singles with any trades.


Biotech Penny Stocks #5: Sesen Bio, Inc. (NASDAQ: SESN)

SESN develops potential cancer treatments.

On June 2, it announced a supply partnership with a China-based company.

“Sesen Bio is entitled to a $2 million milestone payment upon completion of technology transfer to Qilu Pharmaceutical, which the Company believes is on track for completion in 2021.”

Read the full press release here.

On June 8, the company filed a Form 8-K stating, “the Company is expected to be included in the Russell 3000® Index effective after the US market opens on June 28, 2021, according to a preliminary list of additions.”

After the news, the stock made new 52-week highs. It has been in a strong uptrend and it’s consolidating near its highs. I’ll watch for a breakout over $4.17.


Biotech Penny Stocks #6: Vascular Biogenics Ltd. (NASDAQ: VBLT)

VBLT is another biotech company that focuses on developing cancer treatments.

It was on last week’s watchlist for a potential breakout over the $2.45 area. The stock spiked ahead of the company president and CEO’s presentation at the Jefferies Virtual Healthcare Conference on June 3. It broke out and had a huge green day on high volume.

It’s been trading sideways since. I’ll watch it to break out over the $2.75 area.

(Past performance isn’t indicative of future returns.)


Biotech Penny Stocks #7: Agenus Inc. (NASDAQ: AGEN)

AGEN is an immuno-oncology company.

Two doctors presented posters at the American Society of Clinical Oncology annual meeting held from June 4–8. The data presented demonstrated “the differentiation of balstilimab as an anti-PD-1 antibody as well as data from a Phase 1 clinical trial of AGEN2373, a CD137 agonist antibody.”

Read the press release here.

The company also filed a Form 4 on June 7 showing insider buying. The stock had a multi-day breakout above $4.50 on June 8. I’ll watch for it to potentially continue higher.


Biotech Penny Stocks #8: Cerecor Inc. (NASDAQ: CERC)

CERC focuses on developing potential treatments for rare diseases.

On June 7 the company announced it entered into a debt financing agreement in the amount of $35 million.

The stock had a big green day following the news. The next day, it consolidated. It’s on watch for a multi-day breakout over $3.35.


Biotech Penny Stocks #9: PharmaTher Holdings Ltd. (OTCQB: PHRRF)

PHRRF is a biotech company focused on developing psychedelics as a treatment for schizophrenia, autism, depression, and other nervous system disorders.

The stock has been trading high volume since May 17. That’s when the company announced the FDA approved its application to continue with Phase 2 clinical trials for its potential treatment of levodopa-induced dyskinesia in patients with Parkinson’s disease.

Read the full press release here.

On June 8, the stock broke out above multi-month resistance of 40 cents. I’ll watch this one to potentially continue higher. Ideally, it’ll have a news catalyst.


Biotech Penny Stocks #10: VBI Vaccines Inc. (NASDAQ: VBIV)

VBIV develops immuno-oncology and infectious disease vaccines.

On June 8, VBIV announced that the FDA granted Fast Track designation for the company’s cancer vaccine. Which is a potential treatment for recurrent brain cancer.

Read the full press release here.

After the news release, the stock gapped up and had a multi-day breakout over $3.50. I’ll watch for it to potentially breakout over $4 and continue higher.


Get the List of Penny Stocks I’m Watching Delivered to Your Inbox

Want to know which stocks I’m watching each week? Subscribe to my no-cost watchlist. I’ll send my top penny stocks to watch right to your inbox every week. It can help you learn the process I follow for every stock.

penny stock checklist

I’ll say it again … The stocks on my watchlist aren’t an automatic buy. Remember to do your own due diligence and research. If you’re trading without a trading plan, you’re gambling. Don’t be a degenerate gambler — trade smart!

👉🏼 SUBSCRIBE to my no-cost weekly stock watchlist here.


Biotech penny stocks are stocks of small, developmental companies. These companies are usually desperate for cash. They need it to continue developing products and for testing and trials. Trade them with caution…

They’re known to be extremely volatile. They can have huge price swings. One minute they’re flying high on positive news — the next they’re down due to bad trial results, side effects, or stock dilution.

If you’re prepared to take advantage of the price swings, these stocks can offer great trading opportunities…

In my Trading Challenge chat room, my students and I talk about the hottest penny stocks. And many top traders who got their start in the Challenge are now chat moderators who answer questions and help out new students.

If you want to join a community of top traders, apply for my Trading Challenge. I don’t accept everyone. I only want the most dedicated students who are willing to put in the time and effort it takes to become my next top student. Could it be you?

What do you think of these biotech penny stocks to watch? Let me know in the comments … I love to hear from you!


*Please note that these kinds of trading results are not typical and do not reflect the experience of the majority of individuals using our products. From January 1, 2020, to December 31, 2020, typical users of the products and services offered by this website reported earning, on average, an estimated $49.91 in profit. This figure is taken from tracking user accounts on, a trading community platform. It takes years of dedication, hard work, and discipline to learn how to trade. Individual results will vary. Trading is inherently risky. Before making any trades, remember to do your due diligence and never risk more than you can afford to lose.

**Tim Sykes has a minority ownership stake in

The post Top Biotech Penny Stocks to Watch — June 9, 2021 appeared first on Timothy Sykes.